Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-28 · accession 0000950170-24-066881 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-05-30 | 2024-05-28 | CORT | Guyer William | Chief Development Off | S - Sale+OE | $32.00 | -30.0K | 6,039 | -83% | -$960.0K |
| DT | 2024-05-30 | 2024-05-28 | CORT | Guyer William | Chief Development Off | M - OptEx | $19.26 | +30.0K | 36.0K | +497% | +$577.8K |
| DT | 2024-05-30 | 2024-05-28 | CORT | Guyer William | Chief Development Off | M - OptEx | $0.00 | -30.0K | 60.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-28 | S | D | 30,000 | $32.00 | 6,039 | D | — | — | (F1) Includes 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 2 | Common | Common Stock | 2024-05-28 | M | A | 30,000 | $19.26 | 36,039 | D | — | — | (F1) Includes 478 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023 and 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 3 | Derivative | Stock option (right to buy) | 2024-05-28 | M | D | 30,000 | $0.00 | 60,000 | D | $19.26 · — to 2032-02-02 | 30,000 Common Stock | (F3) Fully exercisable. |